Results 131 to 140 of about 38,283 (218)

Pulmonarom^® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells. [PDF]

Front Cell Infect Microbiol
Solano-Gálvez SG, Hernández-Aceves JA, García Lozano A, Wilkins-Rodríguez AA, Rojas Ortega DA, Ibarra A, Albores Méndez EM, Sciutto E, Gutiérrez-Kobeh L, Merchant Larios H, Cabello-Gutiérrez C, Fragoso G, Vázquez-López R.   +12 more
europepmc   +1 more source

FluEvoFormer: A Structure-Guided Generative Foundation Model for Prospective Influenza Antigenic Evolution and Vaccine Strain Selection. [PDF]

Viruses
Agarwal P, Yogarayan S, Sayeed MS.
europepmc   +1 more source

Molecular Surveillance and Genomic Characterization of Influenza A(H3N2) Viruses From a Secondary-Care Surveillance Site in Pakistan During the 2025-2026 Winter Season. [PDF]

J Med Virol
Javed A, Hayat J, Haider SA, Jamal Z, Hakim R, Ali Q, Bullo MMH, Tahir M, Salman M, Javed Y, Waheed Y, Umair M.   +11 more
europepmc   +1 more source

Genomic Surveillance and Phylogenetic Analysis of Influenza A(H1N1) pdm09 and A(H3N2) Viruses in Burkina Faso, 2024. [PDF]

Adv Virol
Sawadogo C, Cissé A, Gouba N, Ilboudo AK, Savadogo M, Lingani M, W O Kabore B, Tarnagda G, Ouoba JB, Dama E, Dahourou A, Gampini S, Ouedraogo H, Tarnagda Z.   +13 more
europepmc   +1 more source

Intranasal delivery of a COBRA-based protein vaccine adjuvanted with c-di-AMP enhances breadth of protective immune responses against seasonal influenza viruses. [PDF]

Front Immunol
Caetano CCS, Prots DA, Thomas MH, Micallef DR, Richardson RA, Ross TM.   +5 more
europepmc   +1 more source

Nanoemulsion adjuvanted COBRA HA vaccine enhances protective antibody titers against H1N1 and H3N2 influenza viruses. [PDF]

Hum Vaccin Immunother
Thomas MH, Ross TM.
europepmc   +1 more source

Molecular Characterization of Influenza A(H3N2) Hemagglutinin Variants Circulating in Western Mexico, 2022. [PDF]

Int J Mol Sci
Hernandez-Gonzalez KM, Carranza-Aranda AS, Muñoz-Valle JF, Muñoz-Miranda LA, Vega-Magaña AN, Pereira-Suárez AL, Nava-Valdivia CA.   +6 more
europepmc   +1 more source

Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis

Journal of the Formosan Medical Association, 2017
Ku, Yee-Huang, Chuang, Yin-Ching, Yu, Wen-Liang   +2 more
openaire   +3 more sources

Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection. [PDF]

Virus Evol
Kikawa C, Huddleston J, Turner SA, Loes AN, Liu J, Gang S, Griffiths T, Drapeau EM, Cowling BJ, Ho F, Leung NHL, Englund JA, Lacombe K, Watanabe S, Hasegawa H, Busch M, Lanteri M, Stone M, Spencer B, Neher RA, Smith DJ, Bedford T, Hensley SE, Bloom JD.   +23 more
europepmc   +1 more source

Capillary-Driven Microfluidic Electrical Screening of Influenza H3N2-Infected A549 Cells Using AgNP-Decorated Laser-Patterned Villous Microstructures. [PDF]

Biosensors (Basel)
Chen Z, Tran MQ.
europepmc   +1 more source